Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 205971
Company: TARO

Products on ANDA 205971

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
IMIQUIMOD	IMIQUIMOD	3.75%	CREAM;TOPICAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 205971

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
01/26/2021	ORIG-1	Approval		STANDARD	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/205971Orig1s000ltr.pdf

Therapeutic Equivalents for ANDA 205971

IMIQUIMOD

CREAM;TOPICAL; 3.75%
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
IMIQUIMOD	IMIQUIMOD	3.75%	CREAM;TOPICAL	Prescription	No	AB	205971	TARO
ZYCLARA	IMIQUIMOD	3.75%	CREAM;TOPICAL	Prescription	Yes	AB	022483	BAUSCH